Top

Published in:

Open Access 01-08-2021 | Human Immunodeficiency Virus | Original Paper

Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission

Authors: Leanne Whiteside-Mansell, LaTunja Sockwell, Daniel Knight, Cynthia Crone

Published in: AIDS and Behavior | Issue 8/2021

Abstract

The southern U.S. has both high HIV and incarceration rates in comparison to its population. As in the rest of the country, HIV prevention is based on education, behavior change, and biomedical efforts, such as pre-exposure prophylaxis (PrEP). This study examined the implementation of an educational intervention and supportive services to obtain PrEP in a population of individuals (N = 218) involved in an Adult Drug Court (ADC) or on probation or parole (P-P). Nearly all ADC and P-P participants self-reported risk behaviors linked to HIV acquisition. Results supported the acceptance and usefulness of the intervention as rated by participants. Participants showed increased knowledge of HIV risks and testing post-education. In multivariate analysis, predictors of interest in using PrEP included low stigma beliefs, specifically their level of prejudice views, high depressive symptoms, and white race. The intervention shows promise. Given the high risk documented for ADC and P-P individuals, HIV prevention is a critical component for increased protective behaviors.

Linley L, Johnson AS, Song R, Wu B, Hu S, Singh S, et al. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveill Suppl Rep. 2018;23:2010–5.

Phillips MM, Quick S, Goodell M. Healthy people 2020 Health Status Report. Little Rock, AR. http://www.uams.edu/phacs/reports/Healthy (2012)

CDC. HIV in the Southern United States. CDC Issue Br. 2019;29:1–4.

Hess K, Johnson AS, Hu X, Li J, Wu B, Yu C et al. Diagnoses of HIV Infection in the United States and Dependent Areas, 2016. HIV Surveill Rep. 2 http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html (2016). Accessed 21 Apr 2018

Evans ME, Labuda SM, Hogan V, Agnew-Brune C, Armstrong J, Karuppiah ABP, et al. HIV infection investigation in a rural area—West Virginia, 2017. Morb Mortal Wkly Rep. 2018;67:257–8.CrossRef

CDC. HIV Prevention in the South. https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-prevention-south.pdf (2018). Accessed 18 Mar 2021

Hedegaard H, Warner M, Miniño A. Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, no 294. Hyattsville, MD (2017). wonder.cdc.gov

Underhill K, Dumont D, Operario D. HIV prevention for adults with criminal justice involvement: a systematic review of HIV risk-reduction interventions in incarceration and community settings. Am J Public Health. 2014;104:e27-53.CrossRef

Festinger DS, Dugosh KL, Metzger DS, Marlowe DB. The prevalence of HIV risk behaviors among felony drug court participants. Drug Court Rev. 2012;8:131–46.PubMedPubMedCentral

10.

Robertson AA, St. Lawrence JS, McCluskey DL. HIV/STI risk behavior of drug court participants. J Offender Rehabil. 2012;51:453–73. https://doi.org/10.1080/10509674.2012.702715.CrossRefPubMedPubMedCentral

11.

Belenko S, Langley S, Crimmins S, Chaple M. HIV risk behaviors, knowledge, and prevention education among offenders under community supervision: a hidden risk group. AIDS Educ Prev. 2004;16:367–85.CrossRef

12.

Substance Abuse and Mental Health Services Administration. Adult drug courts and medication-assisted treatment for opioid dependence. SAMHSA Br. 2014;8:1–8.

13.

Alexandria V. Adult drug court best practice standards volume ii national association of drug court professionals. 17. http://www.nadcp.org/sites/default/files/2014/BestPracticeStandardsVol.II._0.pdf. (2017). Accessed 25 Oct 2017

14.

Rolle CP, Onwubiko U, Jo J, Sheth AN, Kelley CF, Holland DP. PrEP implementation and persistence in a county health department setting in Atlanta, GA. AIDS Behav. 2019;23:296–303. https://doi.org/10.1007/s10461-019-02654-x.CrossRefPubMedPubMedCentral

15.

Hojilla JC, Vlahov D, Crouch PC, Dawson-Rose C, Freeborn K, Carrico A. HIV pre-exposure prophylaxis (PrEP) uptake and retention among men who have sex with men in a community-based sexual health clinic. AIDS Behav. 2018;22:1096–9. https://doi.org/10.1007/s10461-017-2009-x.CrossRefPubMedPubMedCentral

16.

Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services. JAMA Intern Med. 2016;176:75–84. https://doi.org/10.1001/jamainternmed.2015.4683.CrossRefPubMedPubMedCentral

17.

Festinger DS, Dugosh KL, Kurth AE, Metzger DS. Examining the efficacy of a computer facilitated HIV prevention tool in drug court. Drug Alcohol Depend. 2016;162:44–50.CrossRef

18.

Gordon MS, Kinlock TW, McKenzie M, Wilson ME, Rich JD. Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial. AIDS Behav. 2013;17:2022–30. https://doi.org/10.1007/s10461-013-0456-6.CrossRefPubMedPubMedCentral

19.

Pinto RM, Lacombe-Duncan A, Kay ES, Berringer KR. Expanding knowledge about implementation of pre-exposure prophylaxis (PrEP): a methodological review. AIDS Behav. 2019;23:2761–78. https://doi.org/10.1007/s10461-019-02577-7.CrossRefPubMedPubMedCentral

20.

Sophus AI, Mitchell JW. A review of approaches used to increase awareness of pre-exposure prophylaxis (PrEP) in the United States. AIDS Behav. 2019;23:1749–70. https://doi.org/10.1007/s10461-018-2305-0.CrossRefPubMed

21.

Prevent HIV. Ending the HIV Epidemic. CDC. https://www.cdc.gov/endhiv/prevent.html (2020). Accessed 18 Jul 2020

22.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.CrossRef

23.

Baeten JMM, Donnell D, Ndase P, Mugo NRR, Campbell JDD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410. https://doi.org/10.1056/NEJMoa1108524.CrossRefPubMedPubMedCentral

24.

HIV. Healthy People 2020. https://www.healthypeople.gov/2020/topics-objectives/topic/hiv (2017). Accessed 25 Oct 2017

25.

High-Impact HIV Prevention. Policy and Law, HIV/AIDS, CDC. https://www.cdc.gov/hiv/policies/hip/hip.html (2011). Accessed 25 Oct 2017

26.

Siegler AJ, Mouhanna F, Giler RM, Weiss K, Pembleton E, Guest J, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28:841–9. https://doi.org/10.1016/j.annepidem.2018.06.005.CrossRefPubMedPubMedCentral

27.

Siegler AJ, Wiatrek S, Mouhanna F, Amico KR, Dominguez K, Jones J, et al. Validation of the HIV pre-exposure prophylaxis stigma scale: performance of likert and semantic differential scale versions. AIDS Behav. 2020. https://doi.org/10.1007/s10461-020-02820-6.CrossRefPubMedPubMedCentral

28.

PrEP. HIV Basics, HIV/AIDS, CDC. https://www.cdc.gov/hiv/basics/prep.html (2020). Accessed 5 May 2020

29.

CDC. HIV in the Southern United States. CDC Issue Br. 2016;29:1–4.

30.

Chan SS, Chappel AR, Joynt Maddox KE, Hoover KW, Huang YLA, Zhu W, et al. Pre-exposure prophylaxis for preventing acquisition of HIV: a cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015–2016. PLoS Med. 2020. https://doi.org/10.1371/journal.pmed.1003072.CrossRefPubMedPubMedCentral

31.

Clark S. Housing instability: toward a better understanding of frequent residential mobility among America’s urban poor. Center Housing Policy. Available at : https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.365.439&rep=rep1&type=pdf (2010). Accessed 18 Mar 2021

32.

Huang YLA, Zhu W, Smith DK, Harris N, Hoover KW. Hiv pre-exposure prophylaxis, by race and ethnicity—United States 2014–2016. Morb Mortal Wkly Rep. 2018;67:1147–50.CrossRef

33.

Office UCBPI. Majority of African Americans Live in 10 States; New York City and Chicago Are Cities With Largest Black Populations—Census 2000—Newsroom—U.S. Census Bureau

34.

Finlayson T, Cha S, Xia M, Trujillo L, Denson D, Prejean J, et al. Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. MMWR Morb Mortal Wkly Rep. 2019;68:597–603.CrossRef

35.

Elopre L, Kudroff K, Westfall AO, Overton ET, Mugavero MJ. Brief report: the right people, right places, and right practices: disparities in PrEP access among African American men, women, and MSM in the Deep South. J Acquir Immune Defic Syndr. 2017;74:56–9.CrossRef

36.

Ransome Y, Bogart LM, Kawachi I, Kaplan A, Mayer KH, Ojikutu B. Area-level HIV risk and socioeconomic factors associated with willingness to use PrEP among Black people in the U.S. South. Ann Epidemiol. 2020;42:33–41. https://doi.org/10.1016/j.annepidem.2019.11.002.CrossRefPubMed

37.

Black/African American—The Office of Minority Health. https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=61 (2021). Accessed 17 Jan 2021

38.

Ojikutu BO, Bogart LM, Higgins-Biddle M, Dale SK, Allen W, Dominique T, et al. Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav. 2018;22:3576–87. https://doi.org/10.1007/s10461-018-2067-8.CrossRefPubMedPubMedCentral

39.

O’Byrne P, Orser L, Haines M. Active-offer nurse-led PrEP (PrEP-RN) referrals: analysis of uptake rates and reasons for declining. AIDS Behav. 2019;24:1281–9. https://doi.org/10.1007/s10461-019-02745-9.CrossRefPubMedCentral

40.

Golub SA, Fikslin RA, Goldberg MH, Peña SM, Radix A. Predictors of PrEP uptake among patients with equivalent access. AIDS Behav. 2019;23:1917–24. https://doi.org/10.1007/s10461-018-2376-y.CrossRefPubMedPubMedCentral

41.

About Rural Health Care—NRHA. https://www.ruralhealthweb.org/about-nrha/about-rural-health-care (2021). Accessed 19 Jan 2021

42.

Whitehead J, Shaver J, Stephenson R. Outness, stigma, and primary health care utilization among rural LGBT populations. PLoS ONE. 2016. https://doi.org/10.1371/journal.pone.0146139.CrossRefPubMedPubMedCentral

43.

Pellowski JA. Barriers to care for rural people living with HIV: a review of domestic research and health care models. J Assoc Nurses AIDS Care. 2013;24:422–37.CrossRef

44.

Hubach RD, Currin JM, Sanders CA, Kavanaugh KE, Croff JM, Durham AR, et al. Barriers to access and adoption of pre-exposure prophylaxis for the prevention of HIV among men who have sex with men (MSM) in a relatively rural state. AIDS Educ Prev. 2017;29:315.CrossRef

45.

Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS Behav. 2017;21:1236–46.CrossRef

46.

Chop E, Duggaraju A, Malley A, Burke V, Caldas S, Yeh PT, et al. Food insecurity, sexual risk behavior, and adherence to antiretroviral therapy among women living with HIV: A Systematic review. Health Care Women Int. 2017;38:927–44.CrossRef

47.

Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012. https://doi.org/10.1007/s10461-011-0127-4.CrossRefPubMed

48.

Sockwell L, Martel I, Dusenge D, Forsman A. HIV & drug court: how do they fit? In 7th Annual Arkansas Public Heal Conference. Little Rock, AR http://www.nadcpconference.org/wp-content/uploads/2017/06/TS-11.pdf (2017). Accessed 25Oct 2017

49.

Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28:1509–19.CrossRef

50.

Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Natl Med Assoc. 1999;91:439–46.PubMedPubMedCentral

51.

Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–92.CrossRef

52.

HIV Transmission. HIV Basics, HIV/AIDS, CDC. https://www.cdc.gov/hiv/basics/transmission.html (2020). Accessed 18 Jul 2020

53.

HIV Risk Reduction Tool. CDC. https://www.hivrisk.cdc.gov/ (2020). Accessed 18 Jul 2020

54.

Substance Abuse and Mental Health Services Administration. National Minority Substance Abuse/HIV Prevention Initiative Adult Questionnaire. Available at: https://www.samhsa.gov/sites/default/files/adult-questionnaire.pdf (2016). Accessed 18 Mar 2021

55.

PrEP. HIV Basics, HIV/AIDS. CDC. https://www.cdc.gov/hiv/basics/prep.html (2020). Accessed 18 Jul 2020

56.

Centers for Disease Control and Prevention. HIV prevention in the United States: new opportunities, new expectations (2016). Retrieved March 18, 2021 from https://stacks.cdc.gov/view/cdc/39420

57.

Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13:1160–77. https://doi.org/10.1007/s10461-009-9593-3.CrossRefPubMedPubMedCentral

58.

Centers for Disease Control and Prevention. HIV testing implementation guidance for correctional settings. pp. 1–38. Available from: http://www.cdc.gov/hiv/topics/testing/resources/guidelines/correctional-settings/ (2009). Accessed 18 Mar 2021

59.

Millar BM, Starks TJ, Grov C, Parsons JT. Sexual risk-taking in HIV-negative gay and bisexual men increases with depression: results from a U.S. National Study. AIDS Behav. 2017;21:1665–75.CrossRef

60.

Mehrotra ML, Glidden DV, McMahan V, Amico KR, Hosek S, Defechereux P, et al. The effect of depressive symptoms on adherence to daily oral PrEP in men who have sex with men and transgender women: a marginal structural model analysis of The iPrEx OLE Study. AIDS Behav. 2016;20:1527–34.CrossRef

61.

Bogart LM, Ransome Y, Allen W, Higgins-Biddle M, Ojikutu BO. HIV-related medical mistrust, HIV testing, and HIV Risk in the National Survey on HIV in the Black Community. Behav Med. 2019;45:134–42.CrossRef

62.

Ford CL, Wallace SP, Newman PA, Lee SJ, Cunningham WE. Belief in AIDS-related conspiracy theories and mistrust in the government: relationship with HIV testing among at-risk older adults. Gerontologist. 2013;53:973–84.CrossRef

63.

Adams LB, Richmond J, Corbie-Smith G, Powell W. Medical mistrust and colorectal cancer screening among African Americans. J Community Health. 2017;42:1044–61.CrossRef

64.

Golub SA, Gamarel KE. The impact of anticipated HIV stigma on delays in HIV testing behaviors: Findings from a community-based sample of men who have sex with men and transgender women in New York City. AIDS Patient Care STDS. 2013;27:621–7.CrossRef

65.

Paluck EL. How to overcome prejudice. Science. 2016;352:147.CrossRef

66.

Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22:3681–91. https://doi.org/10.1007/s10461-018-2184-4.CrossRefPubMedPubMedCentral

67.

Kalla JL, Broockman DE. Reducing Exclusionary Attitudes through Interpersonal Conversation: Evidence from Three Field Experiments. Am Polit Sci Rev. 2020;114:410–25.CrossRef

68.

Albarracin D, Shavitt S. Attitudes and attitude change. Annu Rev Psychol. 2018. https://doi.org/10.1146/annurev-psych-122216.CrossRefPubMed

69.

The religious states of America, in 22 maps—The Washington Post. https://www.washingtonpost.com/blogs/govbeat/wp/2015/02/26/the-religious-states-of-america-in-22-maps/ (2021). Accessed 30 Jan 2021

70.

Stances of Faiths on LGBTQ Issues: Southern Baptist Convention - HRC. https://www.hrc.org/resources/stances-of-faiths-on-lgbt-issues-southern-baptist-convention (2021). Accessed 30 Jan 2021

71.

Burch-Brown J, Baker W. Religion and reducing prejudice. Gr Process Intergr Relat. 2016;19:784–807. https://doi.org/10.1177/1368430216629566.CrossRef

72.

Yang LH, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 2017;30:378–88.CrossRef

73.

How Christian Groups in America Have Accommodated Changing Beliefs about Homosexuality by Mark Smith : SSRN. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1901737 (2021). Accessed 30 Jan 2021

Title: Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission
Authors: Leanne Whiteside-Mansell
LaTunja Sockwell
Daniel Knight
Cynthia Crone
Publication date: 01-08-2021
Publisher: Springer US
Keyword: Human Immunodeficiency Virus
Published in: AIDS and Behavior / Issue 8/2021
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-021-03219-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2021

Single Room Occupancy Residence: Processes Linking Housing to Not Engaging in HIV Outpatient Care

Mental Health, Coping, and Social Support Among People Living with HIV in the Americas: A Comparative Study Between Argentina and the USA During the SARS-CoV-2 Pandemic

A Pilot Study to Evaluate the Impact of the HIV Infant Tracking System (HITSystem 2.0) on Priority Prevention of Mother-to-Child Transmission (PMTCT) Outcomes

Breaking Down Barriers to HIV Care for Gay and Bisexual Men and Transgender Women: The Advocacy and Other Community Tactics (ACT) Project

Electronic Dissemination of a Web-Based Video Promotes PrEP Contemplation and Conversation Among US Women Engaged in Care at Planned Parenthood

Project ACCLAIM: Intervention Effect on Community Knowledge, Attitudes and Beliefs of Maternal and Child Health and HIV/AIDS in Eswatini, Uganda and Zimbabwe

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page